Moreover, in vivo experiments have shown that Linc00337, Linc00460, Linc00518, Linc00922, Linc01119, and Linc02163 induce tumor growth and metastasis in vivo (Table 1 and Figure 1) which suggests that they could be potential targets for developing novel anti-metastatic therapeutics. This evidence concerns the gene NIHCOLE and neoplasm.